Been digging into why cannabis seems to hit so much harder when B12 deficient or MTHFR positive, and there's a real, multi layered biochemical story here, not just a vague sensitivity.
The direct case precedent
There's a documented case that closely mirrors this exact situation, a 22 year old who used nitrous oxide and cannabis together and developed a full psychotic episode tied to low B12 levels. It resolved after appropriate B12 supplementation, confirming the connection wasn't incidental, correcting the deficiency corrected the psychiatric symptoms.
How B12 deficiency destabilizes the system on its own
B12 deficiency causes buildup of methylmalonic acid and homocysteine, and that buildup is proportionally related to the severity of neuropsychiatric symptoms, not just physical ones like fatigue or numbness. The documented clinical range for B12 deficiency includes psychotic and affective episodes, behavioral disorders, and cognitive impairment. Case reports specifically describe B12 deficiency presenting with hallucinations, delusions of reference, and thought broadcasting severe enough to be misdiagnosed as schizophrenia before the B12 connection was found and treated. The underlying mechanism traces back to B12's role, alongside folate and homocysteine, in the methylation pathway required to produce serotonin and other monoamine neurotransmitters, so when B12 is low, that pathway is disrupted at a chemical level, not just a psychological one.
Where MTHFR fits in, same pathway, different bottleneck
MTHFR converts folate into its active usable form, which methionine synthase then uses, with B12 as a cofactor, to clear homocysteine. There's a documented case of psychosis specifically tied to homozygous MTHFR mutation combined with multiple vitamin deficiencies, which resolved with vitamin supplementation, not by treating the gene itself, since MTHFR variants can only be worked around through the deficiency they create, not corrected directly. There's also a broader framework in the literature called the transmethylation theory of psychosis, proposing that MTHFR variants raising homocysteine and disrupting methylation are a genuine contributing mechanism in some psychotic presentations. A study comparing first episode schizophrenia patients to healthy controls found the schizophrenia group had lower B12 and folate along with elevated homocysteine, with the authors suggesting those abnormalities may have influenced symptom severity.
So MTHFR doesn't cause paranoia by itself, it reduces how efficiently you process folate, which makes it harder to keep homocysteine cleared, the exact same pathway B12 deficiency disrupts. Being homozygous for a MTHFR variant while also B12 deficient means hitting that bottleneck from two directions at once.
What THC does on its own
Separately from any of this, THC is directly documented to cause paranoia. A large randomized, placebo controlled study using intravenous THC found it significantly increased paranoia, negative affect, and anomalous sensory experiences, and reduced working memory, with the negative affect and anomalous experiences fully accounting for the increase in paranoia. This happens in people with completely normal B12 and MTHFR status, so THC doesn't need a deficiency to cause paranoia, it's already capable of doing that on its own in vulnerable individuals.
The receptor level connection
CB1, the main receptor THC acts through in the brain, is itself regulated by DNA methylation, and this regulation appears to be part of what determines individual vulnerability to psychosis from cannabis. Research on human brain tissue found CB1 gene expression and methylation levels change across the lifespan, and this pattern was linked to increased vulnerability to prefrontal cortex dysmaturation from cannabis exposure during adolescence specifically. Animal research found that THC exposure altered DNA methylation at cannabinoid and dopamine receptor genes in the brain, paired with the same social withdrawal and cognitive impairment patterns seen in schizophrenia models. Cannabis exposure has also been shown to directly change DNA methyltransferase and cannabinoid receptor expression in blood cells shortly after smoking, meaning cannabis measurably shifts methylation activity in real time, not just theoretically.
Worth flagging honestly, since it hasn't been studied directly as one pathway, DNA methylation broadly, including at genes like CB1, depends on the same one carbon methylation cycle that B12 and MTHFR are part of, methionine, SAM, and the methyl donor pool methionine synthase maintains. No study tested B12 or MTHFR status specifically alongside CB1 methylation and cannabis induced psychosis in the same subjects, so this is a plausible mechanistic overlap based on shared biochemistry, not a proven three way connection.
Putting it together
Researchers describe cannabis as a component cause of psychosis, meaning it's neither necessary nor sufficient on its own, it interacts with other vulnerability factors to precipitate symptoms. That fits everything here. THC alone can cause paranoia in anyone through its own receptor mechanism. B12 deficiency alone can cause genuine psychiatric symptoms through disrupted neurotransmitter methylation. MTHFR alone just creates a folate processing bottleneck that feeds into that same pathway. Stack all three, impaired methylation from B12 deficiency, a genetic bottleneck from MTHFR making that deficiency harder to correct, and a receptor system that's itself methylation dependent and directly targeted by THC, and you have multiple overlapping reasons why cannabis could hit much harder in this specific combination than it would in someone without any of these factors.
Case report, nitrous oxide and cannabis use with psychotic episode tied to B12 deficiency, resolved with supplementation, https://sciencedirect.com/science/article/abs/pii/S1556370722000529
Psychosis as a symptom of B12 deficiency, case report, https://ncbi.nlm.nih.gov/pmc/articles/PMC9475954
B12 deficiency presenting as psychotic symptoms misdiagnosed as schizophrenia, case report, https://ncbi.nlm.nih.gov/pmc/articles/PMC10787274
B12 deficiency causing mood disorder with psychotic features, adolescent case report, https://ncbi.nlm.nih.gov/pmc/articles/PMC3404901
MTHFR C677T linked psychosis case report, https://ncbi.nlm.nih.gov/pmc/articles/PMC6689870
Transmethylation theory of psychosis and B12/folate/homocysteine in schizophrenia, https://explorationpub.com/Journals/ent/Article/100479
THC causing paranoia through negative affect and anomalous experiences, randomized controlled study, https://ncbi.nlm.nih.gov/pmc/articles/PMC4332941
CB1 receptor CNR1 methylation and adolescent cannabis vulnerability to psychosis, Translational Psychiatry, https://nature.com/articles/s41398-020-0832-8
Perinatal THC exposure altering CB1 and dopamine receptor methylation, schizophrenia model, https://sciencedirect.com/science/article/abs/pii/S0920996417300312
Cannabis smoking altering DNA methyltransferase and cannabinoid receptor expression, Frontiers in Psychiatry, https://frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2022.887700/full
CB1 receptor and NMDA receptor interaction in psychosis vulnerability, cannabis as component cause, https://ncbi.nlm.nih.gov/pmc/articles/PMC3877778